Literature DB >> 22985790

Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.

Ibrahim Alkatout1, Meike Wiedermann, Maret Bauer, Antonia Wenners, Walter Jonat, Wolfram Klapper.   

Abstract

Although tumor surgery aims for a complete resection respecting tumor-specific safety distance, in many cases the most peripheral part, the invasion front, remains in situ. Tumor cells at the tumor margin lose epithelial properties and acquire features of mesenchymal cells. The process of epithelial-to-mesenchymal transition (EMT) has been suggested to be of prime importance for tissue and vessel invasion. Recently, features of EMT were shown to be linked to cells with tumor-founding capability, so- called cancer stem cells (CSC). In this study we show that transcription factors associated with EMT markers Snail, Slug, Twist and Zeb1 are differentially expressed between normal breast epithelium, ductal carcinoma in situ and invasive breast cancer. Both invasive and in situ carcinoma expressed less Slug and Twist and more Zeb1 compared to normal epithelium. Using fluorescence multi-staining the number of potential CSC among invasive cancer cells varied dramatically depending on the staining combination used (18.5% for CD44(+)/CD24(-) and 2.4% for CD49f(+)/CD24(+)). Interestingly, neither transcription factors associated with EMT nor potential CSC counts varied between tumor centre and invasion front. No association of these features with clinical outcome was detected. Our results suggest that reliable in situ markers for EMT are missing for invasive breast cancer. Alternatively, the process of EMT might be activated in tumor cells at the margin as well as the centre. Furthermore, our data show that the bio-markers of CSC detect very variable cell populations within breast cancer, challenging the assumption of a hierarchical organization of CSC in these tumors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985790     DOI: 10.1016/j.yexmp.2012.09.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  18 in total

Review 1.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

Review 2.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

Review 3.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.

Authors:  Aleksandra Markiewicz; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Hanna Majewska; Jolanta Szade; Anna J Żaczek
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

5.  Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.

Authors:  Denise L Cecil; Meredith Slota; Megan M O'Meara; Benjamin C Curtis; Ekram Gad; Yushe Dang; Daniel Herendeen; Lauren Rastetter; Mary L Disis
Journal:  Clin Cancer Res       Date:  2016-12-30       Impact factor: 12.531

Review 6.  Epithelial homeostasis.

Authors:  Ian G Macara; Richard Guyer; Graham Richardson; Yongliang Huo; Syed M Ahmed
Journal:  Curr Biol       Date:  2014-09-08       Impact factor: 10.834

7.  An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location.

Authors:  Kerri-Ann Norton; Aleksander S Popel
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

8.  Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.

Authors:  Ying Liu; Chunying Chen; Pengxu Qian; Xuefei Lu; Baoyun Sun; Xiao Zhang; Liming Wang; Xingfa Gao; Han Li; Zhiyun Chen; Jinglong Tang; Weijie Zhang; Jinquan Dong; Ru Bai; Peter E Lobie; Qingfa Wu; Suling Liu; Huafeng Zhang; Feng Zhao; Max S Wicha; Tao Zhu; Yuliang Zhao
Journal:  Nat Commun       Date:  2015-01-23       Impact factor: 14.919

Review 9.  Clinical significance of epithelial-mesenchymal transition.

Authors:  Konrad Steinestel; Stefan Eder; Andres Jan Schrader; Julie Steinestel
Journal:  Clin Transl Med       Date:  2014-07-02

10.  Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.

Authors:  Fang Wu; Xiaoxia Ye; Peng Wang; Karen Jung; Chengsheng Wu; Donna Douglas; Norman Kneteman; Gilbert Bigras; Yupo Ma; Raymond Lai
Journal:  BMC Cancer       Date:  2013-07-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.